These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31521613)

  • 1. Transcriptome profiling reveals functional variation in Plasmodium falciparum parasites from controlled human malaria infection studies.
    Hoo R; Bruske E; Dimonte S; Zhu L; Mordmüller B; Sim BKL; Kremsner PG; Hoffman SL; Bozdech Z; Frank M; Preiser PR
    EBioMedicine; 2019 Oct; 48():442-452. PubMed ID: 31521613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
    Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE
    Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection.
    Sulyok M; Rückle T; Roth A; Mürbeth RE; Chalon S; Kerr N; Samec SS; Gobeau N; Calle CL; Ibáñez J; Sulyok Z; Held J; Gebru T; Granados P; Brückner S; Nguetse C; Mengue J; Lalremruata A; Sim BKL; Hoffman SL; Möhrle JJ; Kremsner PG; Mordmüller B
    Lancet Infect Dis; 2017 Jun; 17(6):636-644. PubMed ID: 28363637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression Patterns of Plasmodium falciparum Clonally Variant Genes at the Onset of a Blood Infection in Malaria-Naive Humans.
    Pickford AK; Michel-Todó L; Dupuy F; Mayor A; Alonso PL; Lavazec C; Cortés A
    mBio; 2021 Aug; 12(4):e0163621. PubMed ID: 34340541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection.
    Laurens MB; Billingsley P; Richman A; Eappen AG; Adams M; Li T; Chakravarty S; Gunasekera A; Jacob CG; Sim BK; Edelman R; Plowe CV; Hoffman SL; Lyke KE
    PLoS One; 2013; 8(7):e68969. PubMed ID: 23874828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The exception that proves the rule: Virulence gene expression at the onset of Plasmodium falciparum blood stage infections.
    Wichers-Misterek JS; Krumkamp R; Held J; von Thien H; Wittmann I; Höppner YD; Ruge JM; Moser K; Dara A; Strauss J; Esen M; Fendel R; Sulyok Z; Jeninga MD; Kremsner PG; Sim BKL; Hoffman SL; Duffy MF; Otto TD; Gilberger TW; Silva JC; Mordmüller B; Petter M; Bachmann A
    PLoS Pathog; 2023 Jun; 19(6):e1011468. PubMed ID: 37384799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates.
    Gómez-Pérez GP; Legarda A; Muñoz J; Sim BK; Ballester MR; Dobaño C; Moncunill G; Campo JJ; Cisteró P; Jimenez A; Barrios D; Mordmüller B; Pardos J; Navarro M; Zita CJ; Nhamuave CA; García-Basteiro AL; Sanz A; Aldea M; Manoj A; Gunasekera A; Billingsley PF; Aponte JJ; James ER; Guinovart C; Antonijoan RM; Kremsner PG; Hoffman SL; Alonso PL
    Malar J; 2015 Aug; 14():306. PubMed ID: 26245196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
    Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetically engineered
    Murphy SC; Vaughan AM; Kublin JG; Fishbauger M; Seilie AM; Cruz KP; Mankowski T; Firat M; Magee S; Betz W; Kain H; Camargo N; Haile MT; Armstrong J; Fritzen E; Hertoghs N; Kumar S; Sather DN; Pinder LF; Deye GA; Galbiati S; Geber C; Butts J; Jackson LA; Kappe SHI
    Sci Transl Med; 2022 Aug; 14(659):eabn9709. PubMed ID: 36001680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection.
    Lyke KE; Singer A; Berry AA; Reyes S; Chakravarty S; James ER; Billingsley PF; Gunasekera A; Manoj A; Murshedkar T; Laurens MB; Church WP; Garver Baldwin LS; Sedegah M; Banania G; Ganeshan H; Guzman I; Reyes A; Wong M; Belmonte A; Ozemoya A; Belmonte M; Huang J; Villasante E; Sim BKL; Hoffman SL; Richie TL; Epstein JE;
    Clin Infect Dis; 2021 Oct; 73(7):e2424-e2435. PubMed ID: 32920641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.
    Mordmüller B; Supan C; Sim KL; Gómez-Pérez GP; Ospina Salazar CL; Held J; Bolte S; Esen M; Tschan S; Joanny F; Lamsfus Calle C; Löhr SJ; Lalremruata A; Gunasekera A; James ER; Billingsley PF; Richman A; Chakravarty S; Legarda A; Muñoz J; Antonijoan RM; Ballester MR; Hoffman SL; Alonso PL; Kremsner PG
    Malar J; 2015 Mar; 14():117. PubMed ID: 25889522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers.
    van Wolfswinkel ME; Langenberg MCC; Wammes LJ; Sauerwein RW; Koelewijn R; Hermsen CC; van Hellemond JJ; van Genderen PJ
    Malar J; 2017 Nov; 16(1):457. PubMed ID: 29126422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat controlled human malaria infection of healthy UK adults with blood-stage
    Salkeld J; Themistocleous Y; Barrett JR; Mitton CH; Rawlinson TA; Payne RO; Hou MM; Khozoee B; Edwards NJ; Nielsen CM; Sandoval DM; Bach FA; Nahrendorf W; Ramon RL; Baker M; Ramos-Lopez F; Folegatti PM; Quinkert D; Ellis KJ; Poulton ID; Lawrie AM; Cho JS; Nugent FL; Spence PJ; Silk SE; Draper SJ; Minassian AM
    Front Immunol; 2022; 13():984323. PubMed ID: 36072606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole blood transcriptome changes following controlled human malaria infection in malaria pre-exposed volunteers correlate with parasite prepatent period.
    Rothen J; Murie C; Carnes J; Anupama A; Abdulla S; Chemba M; Mpina M; Tanner M; Lee Sim BK; Hoffman SL; Gottardo R; Daubenberger C; Stuart K
    PLoS One; 2018; 13(6):e0199392. PubMed ID: 29920562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposure.
    Abdi AI; Hodgson SH; Muthui MK; Kivisi CA; Kamuyu G; Kimani D; Hoffman SL; Juma E; Ogutu B; Draper SJ; Osier F; Bejon P; Marsh K; Bull PC
    BMC Infect Dis; 2017 Aug; 17(1):585. PubMed ID: 28835215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against
    Epstein JE; Paolino KM; Richie TL; Sedegah M; Singer A; Ruben AJ; Chakravarty S; Stafford A; Ruck RC; Eappen AG; Li T; Billingsley PF; Manoj A; Silva JC; Moser K; Nielsen R; Tosh D; Cicatelli S; Ganeshan H; Case J; Padilla D; Davidson S; Garver L; Saverino E; Murshedkar T; Gunasekera A; Twomey PS; Reyes S; Moon JE; James ER; Kc N; Li M; Abot E; Belmonte A; Hauns K; Belmonte M; Huang J; Vasquez C; Remich S; Carrington M; Abebe Y; Tillman A; Hickey B; Regules J; Villasante E; Sim BKL; Hoffman SL
    JCI Insight; 2017 Jan; 2(1):e89154. PubMed ID: 28097230
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge.
    Talley AK; Healy SA; Finney OC; Murphy SC; Kublin J; Salas CJ; Lundebjerg S; Gilbert P; Van Voorhis WC; Whisler J; Wang R; Ockenhouse CF; Heppner DG; Kappe SH; Duffy PE
    PLoS One; 2014; 9(11):e109654. PubMed ID: 25405724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection.
    Lamsfus Calle C; Fendel R; Singh A; Richie TL; Hoffman SL; Kremsner PG; Mordmüller B
    Front Immunol; 2021; 12():625712. PubMed ID: 33815377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya.
    Hodgson SH; Juma E; Salim A; Magiri C; Njenga D; Molyneux S; Njuguna P; Awuondo K; Lowe B; Billingsley PF; Cole AO; Ogwang C; Osier F; Chilengi R; Hoffman SL; Draper SJ; Ogutu B; Marsh K
    Malar J; 2015 Apr; 14():182. PubMed ID: 25927522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.